{
    "biomarkers": {
        "S10b9Llq": {
            "name": "LEF1",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "LEF1",
                "type": "gene",
                "description": "LEF1 is involved in the Wnt signaling pathway and plays a role in cell adhesion.",
                "findings": "Increased expression of LEF1 was detected in CTCs compared to healthy donors' blood CD45+ white blood cells. It showed high AUC values for detecting CTCs in various cancer types, including colorectal, lung, and breast cancers.",
                "notes": "LEF1's role as an epigenetic biomarker extends beyond colorectal cancer, indicating its potential utility across different cancers.",
                "knowledge": [
                    {
                        "predicate": "increased expression detected",
                        "object": "LEF1"
                    },
                    {
                        "predicate": "high AUC values for CTC detection",
                        "object": "LEF1"
                    }
                ]
            }
        },
        "iux9Fw9K": {
            "name": "CDH17",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "CDH17",
                "type": "gene",
                "description": "CDH17 encodes a protein involved in cell-cell adhesion and signaling.",
                "findings": "Increased expression of CDH17 was detected in CTCs compared to healthy donors' blood CD45+ white blood cells. It showed high AUC values for detecting CTCs in various cancer types, including colorectal, lung, and breast cancers.",
                "notes": "CDH17's role as an epigenetic biomarker extends beyond colorectal cancer, indicating its potential utility across different cancers.",
                "knowledge": [
                    {
                        "predicate": "increased expression detected",
                        "object": "CDH17"
                    },
                    {
                        "predicate": "high AUC values for CTC detection",
                        "object": "CDH17"
                    }
                ]
            }
        },
        "noIriB-A": {
            "name": "SOX4",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "SOX4",
                "type": "gene",
                "description": "SOX4 is involved in the regulation of embryonic development and differentiation.",
                "findings": "Increased expression of SOX4 was detected in CTCs compared to healthy donors' blood CD45+ white blood cells. It showed high AUC values for detecting CTCs in various cancer types, including colorectal, lung, and breast cancers.",
                "notes": "SOX4's role as an epigenetic biomarker extends beyond colorectal cancer, indicating its potential utility across different cancers.",
                "knowledge": [
                    {
                        "predicate": "increased expression detected",
                        "object": "SOX4"
                    },
                    {
                        "predicate": "high AUC values for CTC detection",
                        "object": "SOX4"
                    }
                ]
            }
        },
        "s1SsOnKu": {
            "name": "LEF1, CDH17, SOX4",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "LEF1, CDH17, SOX4",
                "type": "gene panel",
                "description": "A gene panel consisting of LEF1, CDH17, and SOX4 used to detect CTCs in colorectal cancer patients.",
                "findings": "Identified as epigenetic biomarkers with high sensitivity (97%) and specificity (93.3%) for detecting CTCs.",
                "notes": "The panel showed high AUC values in ROC analysis, indicating its effectiveness in distinguishing CTCs from healthy cells.",
                "knowledge": [
                    {
                        "predicate": "high sensitivity and specificity",
                        "object": "LEF1, CDH17, SOX4"
                    },
                    {
                        "predicate": "effective in detecting CTCs",
                        "object": "LEF1, CDH17, SOX4"
                    }
                ]
            }
        },
        "yCDkwtjG": {
            "name": "NMR Proteo-Metabolomics",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "NMR Proteo-Metabolomics",
                "type": "Diagnostic Technology",
                "description": "A technology used for complex diagnostic blood analysis that identifies a range of proteins from one single measurement.",
                "findings": "Demonstrates potential for medical diagnostics by identifying glycosylated acute phase proteins without dependence on the type of glycosylation. It provides information on glycan structures, unlike nephelometric methods.",
                "notes": "Non-destructive and uniquely suitable compared to other diagnostic standards like nephelometry.",
                "knowledge": [
                    {
                        "predicate": "is used for",
                        "object": "medical diagnostics"
                    },
                    {
                        "predicate": "identifies",
                        "object": "glycosylated acute phase proteins"
                    }
                ]
            }
        },
        "bLX3MB1O": {
            "name": "Acute Phase Proteins",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Acute Phase Proteins",
                "type": "Biomarkers",
                "description": "Proteins in the blood whose levels change in response to inflammation.",
                "findings": "NMR observes specifically glycosylated acute phase proteins, providing a novel method for their analysis in medical diagnostics.",
                "notes": "Variable glycosylation profiles of these proteins can be characterized using NMR.",
                "knowledge": [
                    {
                        "predicate": "are observed by",
                        "object": "NMR"
                    },
                    {
                        "predicate": "change levels due to",
                        "object": "inflammation"
                    }
                ]
            }
        },
        "Am0kzJE9": {
            "name": "Glycan Structures",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Glycan Structures",
                "type": "Molecular Feature",
                "description": "Structures of complex carbohydrates that are covalently linked to proteins or lipids.",
                "findings": "NMR yields information on glycan structures, offering insights beyond traditional diagnostic methods like nephelometry which may yield erroneous results if glycan structures interfere with antibody binding.",
                "notes": "Further research is needed for characterizing individual serum glycoprotein glycan NMR profiles.",
                "knowledge": [
                    {
                        "predicate": "are analyzed by",
                        "object": "NMR"
                    },
                    {
                        "predicate": "provide insights beyond",
                        "object": "nephelometry"
                    }
                ]
            }
        },
        "sLD08ohZ": {
            "name": "Inflammatory Conditions",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Inflammatory Conditions",
                "type": "Clinical Condition",
                "description": "Medical conditions characterized by inflammation.",
                "findings": "The clinical potential of NMR proteo-metabolomics will be evaluated by exploring larger cohorts of patients affected by different inflammatory conditions.",
                "notes": "Current findings provide evidence for the feasibility of using NMR in these contexts.",
                "knowledge": [
                    {
                        "predicate": "will be evaluated through",
                        "object": "NMR proteo-metabolomics"
                    },
                    {
                        "predicate": "characterized by",
                        "object": "inflammation"
                    }
                ]
            }
        },
        "T3L1mazs": {
            "name": "miR-126",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "miR-126",
                "type": "microRNA (miRNA)",
                "description": "A microRNA involved in intercellular communication and has been reported as a potential biomarker for cancer diagnosis and prognosis.",
                "findings": "Part of the CEx-miRNAs panel with best predictive data for early CRC stages.",
                "notes": "Included in studies focusing on early, minimally invasive detection methods.",
                "knowledge": [
                    {
                        "predicate": "part of a panel with best predictive data",
                        "object": "miR-126"
                    },
                    {
                        "predicate": "potential biomarker for cancer diagnosis and prognosis",
                        "object": "miR-126"
                    }
                ]
            }
        },
        "OVOf3i-y": {
            "name": "miR-1290",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "miR-1290",
                "type": "microRNA (miRNA)",
                "description": "A microRNA involved in intercellular communication, reported as a potential biomarker.",
                "findings": "Part of the CEx-miRNAs panel with best predictive data for early CRC stages.",
                "notes": "Included in studies focusing on early, minimally invasive detection methods.",
                "knowledge": [
                    {
                        "predicate": "part of a panel with best predictive data",
                        "object": "miR-1290"
                    },
                    {
                        "predicate": "potential biomarker for cancer diagnosis and prognosis",
                        "object": "miR-1290"
                    }
                ]
            }
        },
        "6WCedDI0": {
            "name": "miR-23a",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "miR-23a",
                "type": "microRNA (miRNA)",
                "description": "A microRNA involved in intercellular communication, reported as a potential biomarker.",
                "findings": "Part of the CEx-miRNAs panel with best predictive data for early CRC stages.",
                "notes": "Included in studies focusing on early, minimally invasive detection methods.",
                "knowledge": [
                    {
                        "predicate": "part of a panel with best predictive data",
                        "object": "miR-23a"
                    },
                    {
                        "predicate": "potential biomarker for cancer diagnosis and prognosis",
                        "object": "miR-23a"
                    }
                ]
            }
        },
        "fOOC3xZo": {
            "name": "miR-940",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "miR-940",
                "type": "microRNA (miRNA)",
                "description": "A microRNA involved in intercellular communication, reported as a potential biomarker.",
                "findings": "Part of the CEx-miRNAs panel with best predictive data for early CRC stages.",
                "notes": "Included in studies focusing on early, minimally invasive detection methods.",
                "knowledge": [
                    {
                        "predicate": "part of a panel with best predictive data",
                        "object": "miR-940"
                    },
                    {
                        "predicate": "potential biomarker for cancer diagnosis and prognosis",
                        "object": "miR-940"
                    }
                ]
            }
        },
        "jc_RDtCe": {
            "name": "MSI-H",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "MSI-H",
                "type": "genetic marker",
                "description": "Microsatellite instability-high status in colorectal cancer.",
                "findings": "Confers substantial improvements in clinical outcomes and decreased toxicities through immune checkpoint inhibitors (ICIs), offering patients long-term survival or near curative results.",
                "notes": "",
                "knowledge": [
                    {
                        "predicate": "confers substantial improvements",
                        "object": "MSI-H"
                    },
                    {
                        "predicate": "decreased toxicities through ICIs",
                        "object": "MSI-H"
                    },
                    {
                        "predicate": "offers patients long-term survival or near curative results",
                        "object": "MSI-H"
                    }
                ]
            }
        },
        "XOgrp5QT": {
            "name": "RAS",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "RAS",
                "type": "genetic marker",
                "description": "A gene family involved in signaling pathways that influence cell growth, differentiation, and apoptosis.",
                "findings": "Predictive capacity necessitated a molecular-targeted approach in colorectal cancer (CRC).",
                "notes": "",
                "knowledge": [
                    {
                        "predicate": "predictive capacity",
                        "object": "RAS"
                    },
                    {
                        "predicate": "necessitated a molecular-targeted approach",
                        "object": "RAS"
                    }
                ]
            }
        },
        "sfxxQaJv": {
            "name": "BRAF V600E",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "BRAF V600E",
                "type": "genetic marker",
                "description": "A specific mutation in the BRAF gene found in some cancers, including colorectal cancer.",
                "findings": "Has a negative prognostic value but is now predictive of the response to combined targeted BRAF/EGFR inhibition, doubling survival over standard treatments.",
                "notes": "",
                "knowledge": [
                    {
                        "predicate": "negative prognostic value",
                        "object": "BRAF V600E"
                    },
                    {
                        "predicate": "predictive of response to combined targeted BRAF/EGFR inhibition",
                        "object": "BRAF V600E"
                    },
                    {
                        "predicate": "doubling survival over standard treatments",
                        "object": "BRAF V600E"
                    }
                ]
            }
        },
        "sq8quyR_": {
            "name": "KRAS",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "KRAS",
                "type": "genetic marker",
                "description": "A gene that encodes a protein involved in cell signaling pathways.",
                "findings": "Mutant tumors are more susceptible to ferroptosis induction as a potential clinical strategy due to oncogenic KRAS reprogramming cellular metabolism, limiting glutamine metabolism processes.",
                "notes": "",
                "knowledge": [
                    {
                        "predicate": "more susceptible to ferroptosis induction",
                        "object": "KRAS-mutant tumors"
                    },
                    {
                        "predicate": "oncogenic KRAS reprograms cellular metabolism",
                        "object": "KRAS"
                    }
                ]
            }
        },
        "2mrz09lv": {
            "name": "Ferroptosis",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Ferroptosis",
                "type": "cell death mechanism",
                "description": "A form of regulated cell death associated with the accumulation of lipid peroxides.",
                "findings": "Altered expression of ferroptosis-related genes predicts overall survival (OS) and immune response in CRC. Being explored in combination therapy with ICIs as a promising treatment strategy to increase sensitivity and overcome resistance.",
                "notes": "",
                "knowledge": [
                    {
                        "predicate": "predicts OS and immune response",
                        "object": "ferroptosis"
                    },
                    {
                        "predicate": "being explored in combination therapy with ICIs",
                        "object": "ferroptosis"
                    }
                ]
            }
        },
        "jswf4R-7": {
            "name": "Ki67",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Ki67",
                "type": "Protein",
                "description": "A cellular marker for proliferation, commonly used in oncology to evaluate the growth fraction of a given cell population.",
                "findings": "Used to assess proliferation in tumor samples after treatment with Gemcitabine and Cisplatin.",
                "notes": "Part of immunohistochemistry staining procedures along with other biomarkers.",
                "knowledge": [
                    {
                        "predicate": "used to assess",
                        "object": "Ki67"
                    }
                ]
            }
        },
        "pgljPbNk": {
            "name": "p53",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "p53",
                "type": "Protein",
                "description": "A tumor suppressor protein that regulates the cell cycle and thus functions as a cancer prevention agent by controlling cell division.",
                "findings": "Stained for assessing its presence in tissue samples post treatment.",
                "notes": "Involved in immunohistochemistry to evaluate response to chemotherapy.",
                "knowledge": [
                    {
                        "predicate": "stained for",
                        "object": "p53"
                    }
                ]
            }
        },
        "WC1LQxrk": {
            "name": "Bcl-2",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Bcl-2",
                "type": "Protein",
                "description": "A protein involved in apoptosis regulation, acting as an inhibitor of cell death.",
                "findings": "Included in staining to analyze its expression levels post-treatment with drugs.",
                "notes": "Used alongside other markers for comprehensive tissue analysis.",
                "knowledge": [
                    {
                        "predicate": "included in",
                        "object": "Bcl-2"
                    }
                ]
            }
        },
        "dNej4gZD": {
            "name": "p27",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "p27",
                "type": "Protein",
                "description": "A cyclin-dependent kinase inhibitor that plays a critical role in cell cycle regulation.",
                "findings": "Evaluated through immunohistochemistry to determine its expression after treatment regimens.",
                "notes": "Examined as part of the panel for understanding drug efficacy and tumor response.",
                "knowledge": [
                    {
                        "predicate": "evaluated through",
                        "object": "p27"
                    }
                ]
            }
        },
        "zTtIYamm": {
            "name": "Bax",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Bax",
                "type": "Protein",
                "description": "A pro-apoptotic member of the Bcl-2 protein family, involved in initiating apoptosis.",
                "findings": "Measured to determine levels post chemotherapy treatment.",
                "notes": "Part of a suite of markers used for detailed cellular analysis in tumor studies.",
                "knowledge": [
                    {
                        "predicate": "measured to determine",
                        "object": "Bax"
                    }
                ]
            }
        },
        "WUEm7KSc": {
            "name": "TUNEL assay",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "TUNEL assay",
                "type": "Assay",
                "description": "A method for detecting DNA fragmentation resulting from apoptotic signaling cascades.",
                "findings": "Utilized to quantify apoptosis in tumor samples after drug administration.",
                "notes": "Performed alongside other staining techniques for comprehensive analysis.",
                "knowledge": [
                    {
                        "predicate": "utilized to",
                        "object": "TUNEL assay"
                    }
                ]
            }
        },
        "oIahp00V": {
            "name": "PCNA",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "PCNA",
                "type": "Protein",
                "description": "Proliferating cell nuclear antigen, a protein that acts as a processivity factor for DNA polymerase during DNA replication.",
                "findings": "Stained to assess cell proliferation status in treated tumor samples.",
                "notes": "Part of the panel for evaluating treatment effects on cellular proliferation.",
                "knowledge": [
                    {
                        "predicate": "stained to assess",
                        "object": "PCNA"
                    }
                ]
            }
        },
        "ICoVdSPy": {
            "name": "guanylate cyclase-C",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "guanylate cyclase-C",
                "type": "protein marker",
                "description": "A protein marker used in immunohistochemistry to identify its expression.",
                "findings": "Guanylate cyclase-C immunohistochemistry data were performed and interpreted by Guangjian Ma, Innovative Cellular Therapeutics Co.",
                "notes": "This biomarker was part of the experimental procedures for evaluating cellular therapy responses.",
                "knowledge": [
                    {
                        "predicate": "data interpretation",
                        "object": "guanylate cyclase-C"
                    }
                ]
            }
        },
        "ZrVFFbRd": {
            "name": "Chimeric Antigen Receptor (CAR)",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Chimeric Antigen Receptor (CAR)",
                "type": "genetic marker",
                "description": "A genetic construct used to modify T cells for targeted therapy.",
                "findings": "Vector and cell manufacturing were conducted by Junze He, Shiliu Wu, Xia Wang, and Chang Liu from Innovative Cellular Therapeutics Co. Quality control and testing of the product for the chimeric antigen receptor were done by Wenli Li, Shiquan Lv, Gaopeng Xu, and Nengkai Cen.",
                "notes": "CAR is central to the study's therapy development and was involved in various experimental processes such as vector manufacturing and quality control.",
                "knowledge": [
                    {
                        "predicate": "vector and cell manufacturing",
                        "object": "Chimeric Antigen Receptor"
                    },
                    {
                        "predicate": "quality control and testing",
                        "object": "Chimeric Antigen Receptor"
                    }
                ]
            }
        },
        "IHfMN3Vj": {
            "name": "hCRISPRs",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "hCRISPRs",
                "type": "transcriptional biomarkers",
                "description": "Human CRISPR-derived sequences involved in transcription and diagnostics.",
                "findings": "Research aimed to detect and validate hCRISPRs in transcription and diagnostics, involving computational analyses and various technologies like SHERLOCK and DETECTR.",
                "notes": "hCRISPRs were a primary focus of the research for their potential applications.",
                "knowledge": [
                    {
                        "predicate": "detect and validate",
                        "object": "hCRISPRs"
                    },
                    {
                        "predicate": "involved in transcription and diagnostics",
                        "object": "hCRISPRs"
                    }
                ]
            }
        },
        "hSwHuDJI": {
            "name": "acetone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "acetone",
                "type": "aldehyde/ketone",
                "description": "A chemical compound with a fruity odor that can be found in exhaled breath.",
                "findings": "Acetone might be considered an adequate cancer biomarker, but its concentration changes during activities such as exercising or fasting.",
                "notes": "The acetone concentration in breath is influenced by physical activities and smoking.",
                "knowledge": [
                    {
                        "predicate": "might be considered",
                        "object": "cancer biomarker"
                    },
                    {
                        "predicate": "changes during",
                        "object": "activities such as exercising or fasting"
                    }
                ]
            }
        },
        "wsv1C6Zl": {
            "name": "4-heptanone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "4-heptanone",
                "type": "ketone",
                "description": "A ketone that is one of the VOCs mentioned in relation to cancer research.",
                "findings": "The origins of most VOCs, including 4-heptanone, are unclear and thus not recommended for use as biomarkers.",
                "notes": "There are limitations due to unclear origins.",
                "knowledge": [
                    {
                        "predicate": "origins are unclear",
                        "object": "VOCs"
                    },
                    {
                        "predicate": "not recommended for use as",
                        "object": "biomarkers"
                    }
                ]
            }
        },
        "c-rsFYLJ": {
            "name": "Microbiome Data",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Microbiome Data",
                "type": "Biomarker",
                "description": "The composition and characteristics of microbiota in the human gut associated with colorectal cancer.",
                "findings": "Analysis using Explainable Artificial Intelligence (XAI) to identify biomarkers for colorectal cancer (CRC). The study highlights the use of publicly available datasets and XAI methods to improve understanding and classification of CRC based on microbiome data.",
                "notes": "The research leverages Explainable AI for enhancing model interpretability in identifying potential biomarkers.",
                "knowledge": [
                    {
                        "predicate": "Used in colorectal cancer identification",
                        "object": "Microbiome Data"
                    },
                    {
                        "predicate": "Analyzed with XAI methods",
                        "object": "Microbiome Data"
                    }
                ]
            }
        },
        "VRJ9ePu2": {
            "name": "Explainable Artificial Intelligence (XAI)",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Explainable Artificial Intelligence (XAI)",
                "type": "Methodology",
                "description": "A set of techniques aimed at making the results and decision processes of AI systems more understandable to humans.",
                "findings": "Applied in this study for analyzing microbiome data related to CRC, enabling better interpretation and identification of biomarkers.",
                "notes": "XAI is crucial for enhancing transparency and trustworthiness in AI-driven biomedical research.",
                "knowledge": [
                    {
                        "predicate": "Facilitates interpretation",
                        "object": "Explainable Artificial Intelligence (XAI)"
                    },
                    {
                        "predicate": "Applied to microbiome data analysis",
                        "object": "Explainable Artificial Intelligence (XAI)"
                    }
                ]
            }
        },
        "PH08TAvH": {
            "name": "VOCs",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "VOCs",
                "type": "Biomarkers",
                "description": "Volatile organic compounds detected in exhaled breath that may indicate the presence of colorectal cancer (CRC) or precancerous lesions.",
                "findings": "The study demonstrated that VOC detection with sensor technology could have comparable or even better accuracy for CRC and possibly also precancerous lesion detection than the currently recommended FIT test. The results showed 85% sensitivity and a 94% specificity to detect cancer.",
                "notes": "VOCs identified in this study were different from those reported in previous studies, potentially due to diversity of mass-spectrometry devices, sample collection process, samples origin (breath, blood, urine or faeces), and geographical differences.",
                "knowledge": [
                    {
                        "predicate": "85% sensitivity",
                        "object": "VOCs"
                    },
                    {
                        "predicate": "94% specificity",
                        "object": "VOCs"
                    }
                ]
            }
        },
        "j5oVO5Pc": {
            "name": "Acetone",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Acetone",
                "type": "Compound (Ketones)",
                "description": "A secondary product of lipid peroxidation, generally a good predictor for ketosis.",
                "findings": "Acetone is related to the elevation in CRC patients and can be a marker derived from metabolism under conditions associated with a high oxidation rate of fatty acids.",
                "notes": "Further chemical analysis should compare VOCs in CRC tissues, blood of CRC patients, and breath samples for better correlation.",
                "knowledge": [
                    {
                        "predicate": "marker for ketosis",
                        "object": "Acetone"
                    },
                    {
                        "predicate": "related to lipid peroxidation",
                        "object": "Acetone"
                    }
                ]
            }
        },
        "d6cBAEwQ": {
            "name": "Sensor technology",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Sensor technology",
                "type": "Detection Method",
                "description": "A method used to discriminate between CRC patients and controls, also promising in identifying high-risk lesions like advanced adenomas.",
                "findings": "The study showed that sensor technology could discriminate between CRC patients and non-diseased individuals with high accuracy; it is similarly promising for identifying high-risk lesions.",
                "notes": "Larger studies are needed to further validate these findings, particularly in detecting different stages of adenomas.",
                "knowledge": [
                    {
                        "predicate": "discriminate between CRC patients and controls",
                        "object": "Sensor technology"
                    },
                    {
                        "predicate": "identify high-risk lesions",
                        "object": "Sensor technology"
                    }
                ]
            }
        },
        "as_Iq3mH": {
            "name": "T-antigen",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "T-antigen",
                "type": "glycan biomarker",
                "description": "An abnormal immature glycan signature associated with more aggressive lesions not seen in healthy tissues.",
                "findings": "Stools from more aggressive lesions may exhibit abnormal immature glycan signatures, including the T-antigen.",
                "notes": "T-antigen is part of a glycocode potentially useful for non-invasive cancer diagnostics.",
                "knowledge": [
                    {
                        "predicate": "exhibit abnormal immature glycan signatures",
                        "object": "T-antigen"
                    },
                    {
                        "predicate": "associated with more aggressive lesions",
                        "object": "T-antigen"
                    }
                ]
            }
        },
        "IjRfXFCQ": {
            "name": "Stool glycoproteome",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/KVUjX",
            "details": {
                "name": "Stool glycoproteome",
                "type": "biomarker profile",
                "description": "Characterization of stool glycoproteins that includes molecular targets shared by non-cancerous and cancerous lesions.",
                "findings": "The study provides a characterization of the stool glycoproteome, identifying several molecular targets related to aggressive non-cancerous lesions and cancer.",
                "notes": "These biomarkers hold promise for future pre-clinical assessment in colorectal cancer screening.",
                "knowledge": [
                    {
                        "predicate": "identify molecular targets shared",
                        "object": "Stool glycoproteome"
                    },
                    {
                        "predicate": "related to aggressive non-cancerous lesions and cancer",
                        "object": "Stool glycoproteome"
                    }
                ]
            }
        }
    },
    "documents": {
        "10.1038/s41598-023-42037-w": {
            "doi": "10.1038/s41598-023-42037-w",
            "short_citation": "(Bao-Caamano;2023)",
            "long_citation": "Bao-Caamano, et al., Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer, , 2023"
        },
        "10.1002/anie.202306154": {
            "doi": "10.1002/anie.202306154",
            "short_citation": "(Saraei;2019)",
            "long_citation": "Saraei, et al., Towards a Precise NMR Quantification of Acute Phase Inflammation Proteins from Human Serum, , 2019"
        },
        "10.3390/cancers13184640": {
            "doi": "10.3390/cancers13184640",
            "short_citation": "(Dur\u00e1n-Vin;2021-09-16)",
            "long_citation": "Dur\u00e1n-Vin, et al., CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review, , 2021-09-16"
        },
        "10.3390/cancers16162796": {
            "doi": "10.3390/cancers16162796",
            "short_citation": "(Ashouri;2024-08-08)",
            "long_citation": "Ashouri, et al., Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review, , 2024-08-08"
        },
        "10.1126/sciadv.aaw1317": {
            "doi": "10.1126/sciadv.aaw1317",
            "short_citation": "(Carvalho;2024-12-04)",
            "long_citation": "Carvalho, et al., Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine, , 2024-12-04"
        },
        "10.1001/jamaoncol.2024.3891": {
            "doi": "10.1001/jamaoncol.2024.3891",
            "short_citation": "(Chen;2024-09-19)",
            "long_citation": "Chen, et al., Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer A Nonrandomized Clinical Trial, , 2024-09-19"
        },
        "10.1038/s42003-022-03249-4": {
            "doi": "10.1038/s42003-022-03249-4",
            "short_citation": "(Van Riet;1989)",
            "long_citation": "Van Riet, et al., CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue, , 1989"
        },
        "10.3390/ijms24010129": {
            "doi": "10.3390/ijms24010129",
            "short_citation": "(Chen;2022-12-21)",
            "long_citation": "Chen, et al., Diagnosis by Volatile Organic Compounds in Exhaled Breath from Patients with Gastric and Colorectal Cancers, , 2022-12-21"
        },
        "10.1111/j.2517-6161.1982.tb01195.x": {
            "doi": "10.1111/j.2517-6161.1982.tb01195.x",
            "short_citation": "(D'elia;1982)",
            "long_citation": "D'elia, et al., Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification, , 1982"
        },
        "10.1002/ijc.29701": {
            "doi": "10.1002/ijc.29701",
            "short_citation": "(Amal;2015)",
            "long_citation": "Amal, et al., Breath testing as potential colorectal cancer screening tool, , 2015"
        },
        "10.3390/ijms25073722": {
            "doi": "10.3390/ijms25073722",
            "short_citation": "(Kuppen;2024-03-27)",
            "long_citation": "Kuppen, et al., Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer, , 2024-03-27"
        }
    },
    "lang_info": {
        "phi4:14b/KVUjX": {
            "llm_tag": "phi4:14b",
            "prompt_template": "[BEGIN ARTICLE]:<content></content>\n[END ARTICLE]\n\n[INSTRUCTIONS]\nGenerate list of biomarkers that are topic of the article and for each such biomarker extract name, description, type, findings explicitly mentioned in the article, list of knowledge that consist of 'predicate' about the finding from findings and 'object' which biomarker is subject and related via 'predicate'.\nReturn the response in strict JSON format with the following structure:\n\n[\n  { \"name\": \"biomarker name\",\"type\":\"biomarker type\",\"description\":\"biomarker description\",\"findings\":\"findings about biomarker in article\",\"notes\":\"additional notes important to biomarker\", \"knowledge\":[{'predicate':'some predicate from findings of biomarker','object':'object that relates via predicate to the biomarker' }],\n  { \"name\": \"biomarker2 name\",\"type\":\"biomarker2 type\",\"description\":\"biomarker2 description\",\"findings\":\"findings about biomarker2 in article\",\"notes\":\"additional notes important to biomarker2\", \"knowledge\":[{'predicate':'some predicate from findings of  biomarker2','object':'object that relates via predicate to the biomarker2' }] }\n] \n\nEnsure there is no additional explanation, only return valid JSON.\n"
        }
    }
}